Alexandra Gampel

Alexandra Gampel

Auto-generated profile, based on publicly available information

Alexandra Gampel

Powys Teaching Health Board, Mental Health

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 1998 in Genes & Development
Verified
Journal Article
Open access
PDF file
EMEnrique Martín-Blanco
Enrique Martín-Blanco
AGAlexandra Gampel
Alexandra Gampel
JRJenny Ring
Jenny Ring
KVKanwar Virdee
Kanwar Virdee
NKNikolai Kirov
Nikolai Kirov
AMAlfonso Martinez-Arias
Alfonso Martinez-Arias
The activation of MAPKs is controlled by the balance between MAPK kinase and MAPK phosphatase activities. The latter is mediated by a subset of phosphatases with dual specificity (VH-1 family). Here, we describe a new member of this family encoded by the puckeredgene of Drosophila. Mutations in this gene lead to cytoskeletal defects that result in a failure in dorsal closure related to those associated with mutations in basket, the Drosophila JNK homolog. We show that puckered mutations result in the hyperactivation of DJNK, and that overexpression of puc mimicsbasket mutant phenotypes. We also show that puckeredexpression is itself a consequence of the activity of the JNK pathway and that during dorsal closure, JNK signaling has a dual role: to activate an effector, encoded by decapentaplegic, and an element of negative feedback regulation encoded by puckered.

1 September 1999 in Current Biology
Verified
Journal Article
Closed access
AGAlexandra Gampel
Alexandra Gampel
PPPeter J Parker
Peter J Parker
HMHarry Mellor
Harry Mellor

15 October 2006 in Blood
Verified
Journal Article
Closed access
PDF file
AGAlexandra Gampel
Alexandra Gampel
LMLara Moss
Lara Moss
MJMatt C. Jones
Matt C. Jones
VBVal Brunton
Val Brunton
JNJim C. Norman
Jim C. Norman
HMHarry Mellor
Harry Mellor
Endothelial cells respond to vascular endothelial growth factor (VEGF) to produce new blood vessels. This process of angiogenesis makes a critical contribution during embryogenesis and also in the response to ischemia in adult tissues. We have studied the intracellular trafficking of the major VEGF receptor KDR (VEGFR2). Unlike other related growth factor receptors, we find that a significant proportion of KDR is held in an endosomal storage pool within endothelial cells. We find that KDR can be delivered to the plasma membrane from this intracellular pool and that VEGF stimulates this recycling to the cell surface. KDR recycling appears to be distinct from the previously characterized Rab4- and Rab11-dependent pathways, but, instead, KDR+ recycling vesicles contain Src tyrosine kinase and VEGF-stimulated recycling requires Src activation. Taken together, these data show that intracellular trafficking of KDR is markedly different from other receptor tyrosine kinases and suggest that the regulation of KDR trafficking by VEGF provides a novel mechanism for controlling the sensitivity of endothelial cells to proangiogenic signals.

1 September 2001 in Current Biology
Verified
Journal Article
Closed access
KHKate Heesom
Kate Heesom
AGAlexandra Gampel
Alexandra Gampel
HMHarry Mellor
Harry Mellor
RDRichard M. Denton
Richard M. Denton

1 July 2004 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
MWMatthew Wherlock
Matthew Wherlock
AGAlexandra Gampel
Alexandra Gampel
CFClare Futter
Clare Futter
HMHarry Mellor
Harry Mellor
The Rho family of small GTPases play a pivotal role in the dynamic regulation of the actin cytoskeleton. Recent studies have suggested that these signalling proteins also have wide-ranging functions in membrane trafficking pathways. The Rho family member RhoB was shown to localise to vesicles of the endocytic compartment, suggesting a potential function in regulation of endocytic traffic. In keeping with this, we have previously shown that expression of active RhoB causes a delay in the intracellular trafficking of the epidermal growth factor (EGF) receptor; however, the site of action of RhoB within the endocytic pathway is still unknown. RhoB exists as two prenylated forms in cells: geranylgeranylated RhoB (RhoB-GG) and farnesylated RhoB (RhoB-F). Here we use farnesyltransferase inhibitors (FTIs) to show that prenylation specifies the cellular localisation of RhoB. RhoB-GG localises to multivesicular late endosomes and farnesylated RhoB (RhoB-F) localises to the plasma membrane. The gain of endosomal RhoB-GG elicited by FTI treatment reduces sorting of EGF receptor to the lysosome and increases recycling to the plasma membrane. Ultrastructural analysis shows that activation of RhoB through drug treatment or mutation has no effect the sorting of receptor into late endosomes, but instead inhibits the subsequent transfer of late endosomal receptor to the lysosome.

1 May 2012 in Current Opinion in Hematology
Verified
Journal Article
Closed access
DADavid J. Anstee
David J. Anstee
AGAlexandra Gampel
Alexandra Gampel
ATAshley Mark Toye
Ashley Mark Toye
The present article reviews the recent data concerning the generation of red blood cells from haematopoietic stem cells using laboratory culture and discusses the potential for generating cultured red cells in sufficient quantity for use in transfusion practice. Functional human reticulocytes have been generated from adult peripheral blood haematopoietic stem cells in laboratory culture without the use of heterologous feeder cells and their viability was demonstrated in vivo. Human erythroid progenitor cells lines have been produced from cord and human induced pluripotent stem cell (hiPSC) haematopoietic progenitors. Availability of cultured human red cells from haematopoietic stem cells in the quantities required for transfusion therapy would have a major impact on healthcare provision worldwide. Recent studies provide cause for optimism that this ambitious goal is achievable. Functional adult reticulocytes have been made in culture and shown to survive in vivo. Erythroid progenitor cell lines have been derived from cord blood and from human induced pluripotent stem cells, suggesting that large-scale culture of erythroid cell lines and their differentiation to reticulocytes will be possible. Significant problems remain. More efficient enucleation and induction of maturation to an adult phenotype will be required in order to exploit high proliferative capacity of human embryonic stem cells and hiPSCs. Novel bioengineering solutions will be required to generate cultured red cells in the large quantities required, and in this context, use of synthetic three-dimensional scaffolds to mimic the bone marrow niche holds great promise for the future.